New York Area Mesothelioma Specialists Present to Patients at Special Event
Alexandria, VA (PRWEB) August 30, 2013 -- On September 27, 2013, on the heels of Mesothelioma Awareness Day, the Mesothelioma Applied Research Foundation will host its “Knowledge is Hope” regional conference on malignant mesothelioma, taking place at the Harvard Club in New York City.
This is a one-day conference focusing on patients, families, doctors, and anyone wanting to understand more about malignant mesothelioma. The event agenda features:
- Sessions on standard treatments, ongoing research, environmental/occupational exposure risk, and legal implications.
- Presenters include the following medical professionals:
Dr. Lee Krug, Director of the Mesothelioma Program at Memorial Sloan-Kettering Cancer Center;
Dr. Robert Caccavale, Chief of Thoracic Surgery Division at Somerset Medical Center;
Dr. Raja Flores, Chief of the Division of Thoracic Surgery at Mt. Sinai Medical Center;
Dr. John Chabot, Chief of Division of GI/Endocrine Surgery at New York Presbyterian Hospital / Columbia University Medical Center;
Dr. Mark Robson, Director of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center;
Dr. Marjorie Zauderer, Medical Oncologist at Memorial Sloan-Kettering Cancer Center;
Dr. Harvey Pass, Chief of Thoracic Oncology at New York University Medical Center;
Dr. Andreas Rimner, Radiation Oncologist at Memorial Sloan-Kettering Cancer Center;
Dr. Andy Todd, Associate Professor of Preventative Medicine at Mt. Sinai Hospital,
Liz Blackler, Clinical Social Worker at Memorial Sloan-Kettering Cancer Center;
Mary Hesdorffer, Nurse Practitioner and Executive Director at the Mesothelioma Applied Research Foundation.
Registration is $25 per person (includes all sessions, breakfast and lunch). Registration is available online on the Meso Foundation’s website or by calling the Meso Foundation at (703) 879-3797. Availability is limited and the registration deadline is September 10.
This conference is made possible by an educational grant from Levy Phillips & Konigsberg, LLP.
Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. Approximately 3,000 Americans are diagnosed with mesothelioma every year and an estimated one-third were exposed while serving in the Navy or working in Navy shipyards.
About The Mesothelioma Applied Research Foundation
The Meso Foundation is the only 501(c)3 non-profit organization dedicated to eradicating mesothelioma and easing the suffering caused by it. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish more effective treatments for mesothelioma and, ultimately, a cure for this rare, but extremely aggressive, cancer. To date, the Foundation has awarded over $8.2 million to research.
More information is available at http://www.curemeso.org.
Maja Belamaric, Mesothelioma Applied Research Foundation, http://www.curemeso.org, +1 (703) 879-3822, [email protected]
Share this article